- Home
- VNDA vs OPOF Comparison
VNDA vs OPOF Comparison
Compare VNDA & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- OPOF
- Stock Information
- Founded
- VNDA 2002
- OPOF 1922
- Country
- VNDA United States
- OPOF United States
- Employees
- VNDA N/A
- OPOF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- OPOF Major Banks
- Sector
- VNDA Health Care
- OPOF Finance
- Exchange
- VNDA Nasdaq
- OPOF Nasdaq
- Market Cap
- VNDA 249.4M
- OPOF 212.5M
- IPO Year
- VNDA 2006
- OPOF N/A
- Fundamental
- Price
- VNDA $4.51
- OPOF N/A
- Analyst Decision
- VNDA Strong Buy
- OPOF
- Analyst Count
- VNDA 2
- OPOF 0
- Target Price
- VNDA $16.50
- OPOF N/A
- AVG Volume (30 Days)
- VNDA 404.6K
- OPOF 31.3K
- Earning Date
- VNDA 11-05-2025
- OPOF 10-23-2025
- Dividend Yield
- VNDA N/A
- OPOF 1.33%
- EPS Growth
- VNDA N/A
- OPOF 21.17
- EPS
- VNDA N/A
- OPOF 1.70
- Revenue
- VNDA $203,467,000.00
- OPOF $61,004,000.00
- Revenue This Year
- VNDA $15.45
- OPOF N/A
- Revenue Next Year
- VNDA $37.82
- OPOF N/A
- P/E Ratio
- VNDA N/A
- OPOF $24.72
- Revenue Growth
- VNDA 11.78
- OPOF 4.45
- 52 Week Low
- VNDA $3.81
- OPOF $17.02
- 52 Week High
- VNDA $5.55
- OPOF $42.68
- Technical
- Relative Strength Index (RSI)
- VNDA 46.90
- OPOF 5.67
- Support Level
- VNDA $4.54
- OPOF $40.71
- Resistance Level
- VNDA $4.64
- OPOF $42.43
- Average True Range (ATR)
- VNDA 0.15
- OPOF 0.36
- MACD
- VNDA -0.01
- OPOF -4.48
- Stochastic Oscillator
- VNDA 8.89
- OPOF 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.